Varenicline and Combined Nicotine Replacement Therapy (NRT) for Initial Smoking Cessation and Rescue Treatment in Smokers: A Randomized Pilot Trial

Trial Profile

Varenicline and Combined Nicotine Replacement Therapy (NRT) for Initial Smoking Cessation and Rescue Treatment in Smokers: A Randomized Pilot Trial

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 28 May 2017

At a glance

  • Drugs Varenicline (Primary) ; Nicotine; Nicotine
  • Indications Smoking withdrawal
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 May 2017 Planned number of patients changed from 310 to 500.
    • 14 May 2015 Planned primary completion date changed from 1 Jul 2019 to 1 May 2019 as reported by ClinicalTrials.gov record.
    • 14 May 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top